Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Neurosurgical Review
Erschienen in: Neurosurgical Review 3/2017

17.11.2016 | Original Article

Multimodal treatment of craniofacial osteosarcoma with high-grade histology. A single-center experience over 35 years

verfasst von: Marton König, Terje A. Osnes, Ingvild Lobmaier, Bodil Bjerkehagen, Øyvind S. Bruland, Kirsten Sundby Hall, Torstein R. Meling

Erschienen in: Neurosurgical Review | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

High-grade craniofacial osteosarcoma (CFOS) is an aggressive malignancy with a poor prognosis. Our goals were to evaluate treatment outcomes in those treated at a single referral institution over 35 years and to compare our results to the available literature. A retrospective analysis of all 42 patients treated between 1980 and 2015 at Oslo University Hospital, Norway, identified in a prospectively collected database, was conducted. Mean follow-up was 79.6 months. Overall survival at 2 and 5 years was 70.5 and 44.7%, respectively. The corresponding disease-specific survival rates were 73.0 and 49.8%. Treatment was surgery only in eight cases. Additional therapy was administered in 34 patients: chemotherapy in nine, radiotherapy in seven, and a combination of these in 18 cases. Stratified analysis by resection margins demonstrated significantly better survival at 2 and 5 years after radical surgical treatment. Neoadjuvant chemotherapy and subsequent adequate surgery resulted in better survival than surgery alone. Half of the patients either had a primary or familial cancer predisposition. This is the largest single-center study conducted on high-grade CFOS to date. Our experience indicates that neoadjuvant chemotherapy with complete surgical resection significantly improved survival, compared to surgery alone.
Literatur
1.
Hogendoorn PC, Group EEW, Athanasou N, Bielack S, De Alava E, Dei Tos AP et al (2010) Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v204–v213CrossRefPubMed
2.
Mirabello L, Troisi RJ, Savage SA (2009) International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer 125(1):229–234CrossRefPubMedPubMedCentral
3.
Fletcher C, Bridge J, Hogendoorn PC, Mertens F (2013) WHO classification of tumours of soft tissue and bone, 4th edn. International Agency for Research on Cancer, Lyon
4.
Berner K, Johannesen TB, Berner A, Haugland HK, Bjerkehagen B, Bohler PJ et al (2015) Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma. Acta Oncol 54(1):25–33CrossRefPubMed
5.
Tran LM, Mark R, Meier R, Calcaterra TC, Parker RG (1992) Sarcomas of the head and neck. Prognostic factors and treatment strategies. Cancer 70(1):169–177CrossRefPubMed
6.
Saeter G, Bruland OS, Folleras G, Boysen M, Hoie J (1996) Extremity and non-extremity high-grade osteosarcoma—the Norwegian Radium Hospital experience during the modern chemotherapy era. Acta Oncol 35(Suppl 8):129–134CrossRefPubMed
7.
Thiele OC, Freier K, Bacon C, Egerer G, Hofele CM (2008) Interdisciplinary combined treatment of craniofacial osteosarcoma with neoadjuvant and adjuvant chemotherapy and excision of the tumour: a retrospective study. Br J Oral Maxillofac Surg 46(7):533–536CrossRefPubMed
8.
Berner K, Hall KS, Monge OR, Weedon-Fekjaer H, Zaikova O, Bruland OS (2015) Prognostic factors and treatment results of high-grade osteosarcoma in Norway: a scope beyond the “classical” patient. Sarcoma 2015:516843PubMedPubMedCentral
9.
Luetke A, Meyers PA, Lewis I, Juergens H (2014) Osteosarcoma treatment—where do we stand? A state of the art review. Cancer Treat Rev 40(4):523–532CrossRefPubMed
10.
Huvos AG, Rosen G, Marcove RC (1977) Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med 101(1):14–18PubMed
11.
Fletcher C, Unni K (2002) Pathology and genetics of tumours of soft tissue and bone. IARC Press, Lyon
12.
Saeter G, Bruland O (1998) High-grade osteosarcoma: the scope beyond the classical patient. Towards the Eradication of Osteosarcoma Metastasis-An Odyssey 21-3
13.
Kaplan E, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481CrossRef
14.
Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50(3):163–170PubMed
15.
Cox D (1972) Regression models and life tables. J R Stat Soc B 34:187–220
16.
Fisher RA (1922) On the interpretation of Χ2 from contingency tables, and the calculation of P. J R Stat Soc 85(1):87–94CrossRef
17.
Bruland OS, Bauer H, Alvegaard T, Smeland S (2009) Treatment of osteosarcoma. The Scandinavian Sarcoma Group experience. Cancer Treat Res 152:309–318CrossRefPubMed
18.
Huber GF, Dziegielewski P, Wayne Matthews T, Dort JC (2008) Head and neck osteosarcoma in adults: the province of Alberta experience over 26 years. J Otolaryngol Head Neck Surg 37(5):738–743PubMed
19.
Sturgis EM, Potter BO (2003) Sarcomas of the head and neck region. Curr Opin Oncol 15(3):239–252CrossRefPubMed
20.
Guadagnolo BA, Zagars GK, Raymond AK, Benjamin RS, Sturgis EM (2009) Osteosarcoma of the jaw/craniofacial region: outcomes after multimodality treatment. Cancer 115(14):3262–3270CrossRefPubMed
21.
Kassir RR, Rassekh CH, Kinsella JB, Segas J, Carrau RL, Hokanson JA (1997) Osteosarcoma of the head and neck: meta-analysis of nonrandomized studies. Laryngoscope 107(1):56–61CrossRefPubMed
22.
Schwarz R, Bruland O, Cassoni A, Schomberg P, Bielack S (2009) The role of radiotherapy in osteosarcoma. Cancer Treat Res 152:147–164CrossRefPubMed
23.
Kammerer PW, Shabazfar N, Vorkhshori Makoie N, Moergel M, Al-Nawas B (2012) Clinical, therapeutic and prognostic features of osteosarcoma of the jaws—experience of 36 cases. J Craniomaxillofac Surg 40(6):541–548CrossRefPubMed
24.
Patel SG, Meyers P, Huvos AG, Wolden S, Singh B, Shaha AR et al (2002) Improved outcomes in patients with osteogenic sarcoma of the head and neck. Cancer 95(7):1495–1503CrossRefPubMed
25.
26.
Jasnau S, Meyer U, Potratz J, Jundt G, Kevric M, Joos UK et al (2008) Craniofacial osteosarcoma experience of the cooperative German-Austrian-Swiss osteosarcoma study group. Oral Oncol 44(3):286–294CrossRefPubMed
27.
Mendenhall WM, Fernandes R, Werning JW, Vaysberg M, Malyapa RS, Mendenhall NP (2011) Head and neck osteosarcoma. Am J Otolaryngol 32(6):597–600CrossRefPubMed
28.
Ferrari D, Codeca C, Battisti N, Broggio F, Crepaldi F, Violati M et al (2014) Multimodality treatment of osteosarcoma of the jaw: a single institution experience. Med Oncol 31(9):171CrossRefPubMed
29.
Mark RJ, Sercarz JA, Tran L, Dodd LG, Selch M, Calcaterra TC (1991) Osteogenic sarcoma of the head and neck. The UCLA experience. Arch Otolaryngol Head Neck Surg 117(7):761–766CrossRefPubMed
30.
Oda D, Bavisotto LM, Schmidt RA, McNutt M, Bruckner JD, Conrad EU 3rd et al (1997) Head and neck osteosarcoma at the University of Washington. Head Neck 19(6):513–523CrossRefPubMed
31.
Ha PK, Eisele DW, Frassica FJ, Zahurak ML, McCarthy EF (1999) Osteosarcoma of the head and neck: a review of the Johns Hopkins experience. Laryngoscope 109(6):964–969CrossRefPubMed
32.
Gorsky M, Epstein JB (2000) Craniofacial osseous and chondromatous sarcomas in British Columbia—a review of 34 cases. Oral Oncol 36(1):27–31CrossRefPubMed
33.
Smith RB, Apostolakis LW, Karnell LH, Koch BB, Robinson RA, Zhen W et al (2003) National Cancer Data Base report on osteosarcoma of the head and neck. Cancer 98(8):1670–1680CrossRefPubMed
34.
Garrington GE, Scofield HH, Cornyn J, Hooker SP (1967) Osteosarcoma of the jaws. Analysis of 56 cases. Cancer 20(3):377–391CrossRefPubMed
35.
Roca AN, Smith JL Jr, Jing BS (1970) Osteosarcoma and parosteal osteogenic sarcoma of the maxilla and mandible: study of 20 cases. Am J Clin Pathol 54(4):625–636CrossRefPubMed
36.
Caron AS, Hajdu SI, Strong EW (1971) Osteogenic sarcoma of the facial and cranial bones. A review of forty-three cases. Am J Surg 122(6):719–725CrossRefPubMed
37.
Russ JE, Jesse RH (1980) Management of osteosarcoma of the maxilla and mandible. Am J Surg 140(4):572–576CrossRefPubMed
38.
Nora FE, Unni KK, Pritchard DJ, Dahlin DC (1983) Osteosarcoma of extragnathic craniofacial bones. Mayo Clin Proc 58(4):268–272PubMed
39.
Clark JL, Unni KK, Dahlin DC, Devine KD (1983) Osteosarcoma of the jaw. Cancer 51(12):2311–2316CrossRefPubMed
40.
Forteza G, Colmenero B, Lopez-Barea F (1986) Osteogenic sarcoma of the maxilla and mandible. Oral Surg Oral Med Oral Pathol 62(2):179–184CrossRefPubMed
41.
Bertoni F, Dallera P, Bacchini P, Marchetti C, Campobassi A (1991) The Istituto Rizzoli-Beretta experience with osteosarcoma of the jaw. Cancer 68(7):1555–1563CrossRefPubMed
42.
Vege DS, Borges AM, Aggrawal K, Balasubramaniam G, Parikh DM, Bhaser B (1991) Osteosarcoma of the craniofacial bones. A clinico-pathological study. J Craniomaxillofac Surg 19(2):90–93CrossRefPubMed
43.
Wanebo HJ, Koness RJ, MacFarlane JK, Eilber FR, Byers RM, Elias EG et al (1992) Head and neck sarcoma: report of the Head and Neck Sarcoma Registry. Society of Head and Neck Surgeons Committee on Research. Head Neck 14(1):1–7CrossRefPubMed
44.
Salvati M, Ciappetta P, Raco A (1993) Osteosarcomas of the skull. Clinical remarks on 19 cases. Cancer 71(7):2210–2216CrossRefPubMed
45.
Delgado R, Maafs E, Alfeiran A, Mohar A, Barrera JL, Zinser J et al (1994) Osteosarcoma of the jaw. Head Neck 16(3):246–252CrossRefPubMed
46.
Koka V, Vericel R, Lartigau E, Lusinchi A, Schwaab G (1994) Sarcomas of nasal cavity and paranasal sinuses: chondrosarcoma, osteosarcoma and fibrosarcoma. J Laryngol Otol 108(11):947–953CrossRefPubMed
47.
August M, Magennis P, Dewitt D (1997) Osteogenic sarcoma of the jaws: factors influencing prognosis. Int J Oral Maxillofac Surg 26(3):198–204CrossRefPubMed
48.
van Es RJ, Keus RB, van der Waal I, Koole R, Vermey A (1997) Osteosarcoma of the jaw bones. Long-term follow up of 48 cases. Int J Oral Maxillofac Surg 26(3):191–197CrossRefPubMed
49.
Canadian Society of O-H, Neck Surgery Oncology Study G (2004) Osteogenic sarcoma of the mandible and maxilla: a Canadian review (1980-2000). J Otolaryngol 33(3):139–144CrossRef
50.
Fernandes R, Nikitakis NG, Pazoki A, Ord RA (2007) Osteogenic sarcoma of the jaw: a 10-year experience. J Oral Maxillofac Surg 65(7):1286–1291CrossRefPubMed
51.
Laskar S, Basu A, Muckaden MA, D’Cruz A, Pai S, Jambhekar N et al (2008) Osteosarcoma of the head and neck region: lessons learned from a single-institution experience of 50 patients. Head Neck 30(8):1020–1026CrossRefPubMed
52.
Paparella ML, Olvi LG, Brandizzi D, Keszler A, Santini-Araujo E, Cabrini RL (2013) Osteosarcoma of the jaw: an analysis of a series of 74 cases. Histopathology 63(4):551–557PubMed
53.
Lim S, Lee S, Rha SY, Rho JK (2013) Craniofacial osteosarcoma: single institutional experience in Korea. Asia Pac J Clin Oncol
54.
Smeele LE, Kostense PJ, van der Waal I, Snow GB (1997) Effect of chemotherapy on survival of craniofacial osteosarcoma: a systematic review of 201 patients. J Clin Oncol 15(1):363–367CrossRefPubMed
55.
Smeele LE, Snow GB, van der Waal I (1998) Osteosarcoma of the head and neck: meta-analysis of the nonrandomized studies. Laryngoscope 108(6):946CrossRefPubMed
56.
Smeele LE, van der Wal JE, van Diest PJ, van der Waal I, Snow GB (1994) Radical surgical treatment in craniofacial osteosarcoma gives excellent survival. A retrospective cohort study of 14 patients. Eur J Cancer B Oral Oncol 30B(6):374–376CrossRefPubMed
57.
Akbiyik N, Alexander LL (1981) Osteosarcoma of the maxilla treated with radiation therapy and surgery. J Natl Med Assoc 73(4):355–356PubMedPubMedCentral
58.
Briant TD, Bird R (1981) Osteogenic sarcoma of the mandible. J Otolaryngol 10(2):149–161PubMed
59.
deFries HO, Perlin E, Leibel SA (1979) Treatment of osteogenic sarcoma of the mandible. Arch Otolaryngol 105(6):358–359CrossRefPubMed
60.
Goepfert H, Ballantyne AJ, Matalon V, McCarthy E (1979) Osteogenic sarcoma of the mandible: surgical resection and prosthetic rehabilitation. Otolaryngol Head Neck Surg (1979) 87(4):417–419CrossRef
61.
Gomez AC, Youmans RD, Chambers RG (1960) Osteogenic sarcoma of the mandible. A method of treatment. Am J Surg 100:613–616CrossRefPubMed
62.
Hadley C, Gressot LV, Patel AJ, Wang LL, Flores RJ, Whitehead WE et al (2014) Osteosarcoma of the cranial vault and skull base in pediatric patients. J Neurosurg Pediatr 13(4):380–387CrossRefPubMed
63.
Kragh LV, Dahlin DC, Erich JB (1958) Osteogenic sarcoma of the jaws and facial bones. Am J Surg 96(4):496–505CrossRefPubMed
64.
65.
Mardinger O, Givol N, Talmi YP, Taicher S (2001) Osteosarcoma of the jaw. The Chaim Sheba Medical Center experience. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91(4):445–451CrossRefPubMed
66.
Schwartz DT, Alpert M (1963) The clinical course of mandibular osteogenic sarcoma. Oral Surg Oral Med Oral Pathol 16:769–776CrossRefPubMed
67.
van den Berg H, Schreuder WH, de Lange J (2013) Osteosarcoma: a comparison of jaw versus nonjaw localizations and review of the literature. Sarcoma 2013:316123PubMedPubMedCentral
68.
Sundaresan N, Huvos AG, Rosen G, Galicich JH (1985) Combined-modality treatment of osteogenic sarcoma of the skull. J Neurosurg 63(4):562–567CrossRefPubMed
69.
Huvos AG, Sundaresan N, Bretsky SS, Butler A (1985) Osteogenic sarcoma of the skull. A clinicopathologic study of 19 patients. Cancer 56(5):1214–1221CrossRefPubMed
70.
Boon E, van der Graaf WT, Gelderblom H, Tesselaar ME, van Es RJ, Oosting SF, et al. (2016) Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adults. Head Neck
71.
72.
Isakoff MS, Bielack SS, Meltzer P, Gorlick R (2015) Osteosarcoma: current treatment and a collaborative pathway to success. J Clin Oncol 33(27):3029–3035CrossRefPubMedPubMedCentral
73.
Bielack SS, Wulff B, Delling G, Gobel U, Kotz R, Ritter J et al (1995) Osteosarcoma of the trunk treated by multimodal therapy: experience of the Cooperative Osteosarcoma study group (COSS). Med Pediatr Oncol 24(1):6–12CrossRefPubMed
74.
Bilsky MH, Bentz B, Vitaz T, Shah J, Kraus D (2005) Craniofacial resection for cranial base malignancies involving the infratemporal fossa. Neurosurgery 57(4 Suppl):339–347 discussion -47PubMedPubMedCentral
75.
Anninga JK, Gelderblom H, Fiocco M, Kroep JR, Taminiau AH, Hogendoorn PC et al (2011) Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand? Eur J Cancer 47(16):2431–2445CrossRefPubMed
76.
Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM et al (2015) Methotrexate, doxorubicin, and cisplatin (MAP) plus maintenance pegylated interferon alfa-2b versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: first results of the EURAMOS-1 good response randomized controlled trial. J Clin Oncol 33(20):2279–2287CrossRefPubMedPubMedCentral
77.
Ferrari S, Smeland S, Mercuri M, Bertoni F, Longhi A, Ruggieri P et al (2005) Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol 23(34):8845–8852CrossRefPubMed
78.
Bhandare N, Monroe AT, Morris CG, Bhatti MT, Mendenhall WM (2005) Does altered fractionation influence the risk of radiation-induced optic neuropathy? Int J Radiat Oncol Biol Phys 62(4):1070–1077CrossRefPubMed
Metadaten
Titel
Multimodal treatment of craniofacial osteosarcoma with high-grade histology. A single-center experience over 35 years
verfasst von
Marton König
Terje A. Osnes
Ingvild Lobmaier
Bodil Bjerkehagen
Øyvind S. Bruland
Kirsten Sundby Hall
Torstein R. Meling
Publikationsdatum
17.11.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Neurosurgical Review / Ausgabe 3/2017
Print ISSN: 0344-5607
Elektronische ISSN: 1437-2320
DOI
https://doi.org/10.1007/s10143-016-0802-z

Weitere Artikel der Ausgabe 3/2017

Neurosurgical Review 3/2017 Zur Ausgabe

Original Article

Application of actuator-driven pulsed water jet in aneurysmal subarachnoid hemorrhage surgery: its effectiveness for dissection around ruptured aneurysmal walls and subarachnoid clot removal

Original Article

Comparison between smaller ruptured intracranial aneurysm and larger un-ruptured intracranial aneurysm: gene expression profile analysis

Technical Note

Two surgeons four-hand microneurosurgery with universal holder system: technical note

Original Article

Vertebral artery and osseous anomalies characteristic at the craniocervical junction diagnosed by CT and 3D CT angiography in normal Czech population: analysis of 511 consecutive patients

Case Report

Uneven cerebral hemodynamic change as a cause of neurological deterioration in the acute stage after direct revascularization for moyamoya disease: cerebral hyperperfusion and remote ischemia caused by the ‘watershed shift’

Original Article

The value of quantitative sensory testing in spine research

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.